Furthermore, most studies have focused on the use of EGFR inhibitors in combination with other treatments, such as chemotherapy or radiation therapy, and only a very few studies have investigated the use of EGFR inhibitors as a monotherapy in cervical cancer. The gene discussed is EGFR; the disease is cervical carcinoma.